Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
Titel:
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
Auteur:
Iland, Harry J Collins, Marnie Bradstock, Ken Supple, Shane G Catalano, Alberto Hertzberg, Mark Browett, Peter Grigg, Andrew Firkin, Frank Campbell, Lynda J Hugman, Amanda Reynolds, John Di Iulio, Juliana Tiley, Campbell Taylor, Kerry Filshie, Robin Seldon, Michael Taper, John Szer, Jeff Moore, John Bashford, John Seymour, John F